iRhythm Holdings, Inc. reported $825M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $825M (to Q2 2026). Net income: −$14M, trailing twelve months to Q2 2026. Free cash flow: $39M, trailing twelve months to Q2 2026. Operating margin: −3.1%, trailing twelve months to Q2 2026.

IRTCiRhythm Holdings, Inc.

Healthcare

$106.74-39% 1Y

$106.74

$101.7952 weeks$189.25

IRTC as reported

iRhythm Holdings, Inc. reported $825M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed.

$825M

Revenue, trailing twelve months · to Q2 2026 · +26% against the twelve months before

Net income: −$14M
Net income · −85% year on year · trailing twelve months to Q2 2026
Free cash flow: $39M
Free cash flow · +40% year on year · trailing twelve months to Q2 2026
Operating margin: −3.1%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for IRTC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$825M	+26%	Q2 2026
Net income	−$14M	−85%	Q2 2026
EPS	−$0.42	−86%	Q2 2026
Gross margin	71%	n/a	Q2 2026
Operating margin	−3.1%	n/a	Q2 2026
Net margin	−1.8%	n/a	Q2 2026
ROE	−24%	n/a	Q2 2026
ROA	−3.4%	n/a	Q2 2026
ROIC	−91%	n/a	Q4 2023 · 10 quarters behind
Free cash flow	$39M	+40%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.